लोड हो रहा है...
Aplidin in patients with advanced dedifferentiated liposarcomas: a French Sarcoma Group Single-Arm Phase II study
BACKGROUND: Preclinical data have suggested a therapeutic role of JUN pathway activation in dedifferentiated liposarcoma (DDLPS) tumorigenesis. Aplidin(®) is a drug inducing apoptosis through a strong, sustained activation of c-Jun NH2-terminal kinase. METHODS: This phase II trial included patients...
में बचाया:
| में प्रकाशित: | Ann Oncol |
|---|---|
| मुख्य लेखकों: | , , , , , , , |
| स्वरूप: | Artigo |
| भाषा: | Inglês |
| प्रकाशित: |
Oxford University Press
2015
|
| विषय: | |
| ऑनलाइन पहुंच: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4478976/ https://ncbi.nlm.nih.gov/pubmed/26041763 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/annonc/mdv195 |
| टैग : |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|